National Institutes of Health
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, up to $25.0M, closing January 7, 2028.
Overview
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized…